• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS TERUMO BIOMATERIALS CORP. MISHIMA FACTORY OSFERION; FILLER, BONE VOID, CALCIUM COMPOUND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS TERUMO BIOMATERIALS CORP. MISHIMA FACTORY OSFERION; FILLER, BONE VOID, CALCIUM COMPOUND Back to Search Results
Catalog Number 60MA4
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Implant Pain (4561)
Event Type  Injury  
Event Description
A patient underwent around the knee osteotomy (ako).The surgeon in charge of the patient fixed the osteotomized bone with a bone plate and bone screws and filled the space created after the osteotomy with this product (bone void filler).Since the patient complained of a pain in the patient's affected lower limb after the ako, the surgeon chose to slow the pace of post-operative rehabilitation and monitor the progress of the patient carefully.About three months after the ako, the surgeon detected plate breakage and nonunion and decided to carry out reoperation.During the reoperation, the surgeon freshened the fracture ends, implanted a different artificial bone, and then fixed the osteotomized bone anew with a different bone plate and bone screws dedicated to the bone plate.
 
Manufacturer Narrative
The device history record was reviewed, and no irregularities were noted.The plate breakage in this case probably caused by the excessive force applied to the position of the plate and screws.We concluded that the quality of this product has no relation to this event.The osferion bone void filler package insert status in the following section: warning and precaution: 1.Important basic precautions (3)when load bearing capacity has been weakened or reduced due to fractures, etc., osferion should only be used if the bone can be reliably immobilized by using external or internal fixations etc.Otherwise, compaction of fractures may occur.(4) if necessary, the fracture should be stabilized using external or internal fixations to prevent post-implantation migration or extrusion of the osferion due to loosening.Adverse events: fracture, fever, pain, local sensation, red flare, inflammation.This report is being submitted as a medical device report is an abundance of caution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OSFERION
Type of Device
FILLER, BONE VOID, CALCIUM COMPOUND
Manufacturer (Section D)
OLYMPUS TERUMO BIOMATERIALS CORP. MISHIMA FACTORY
454-1 higashino,nagaizumi-cho
sunto-gun
shizuoka, 411-0 931
JA  411-0931
Manufacturer (Section G)
OLYMPUS TERUMO BIOMATERIALS CORP.
1-50-1 sasazuka,shibuya-ku
tokyo, 151-0 073
JA   151-0073
Manufacturer Contact
jiro hirai
1-50-1 sasazuka,shibuya-ku
tokyo, 151-0-073
JA   151-0073
MDR Report Key18611108
MDR Text Key334141609
Report Number3007738819-2024-00001
Device Sequence Number1
Product Code MQV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K080065
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 01/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/30/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number60MA4
Device Lot NumberM22Z06D447
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/06/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age65 YR
Patient SexMale
Patient Weight88 KG
-
-